NovoNorm fremkaldte en tilfredsstillende insulinrespons på et måltid inden for 30 minutter, efter at en dosis var blevet indtaget af patienter med type 2- diabetes.
NovoNorm produced a good insulin response to a meal within 30 minutes of being dosed in type 2 diabetes patients, leading to a blood glucose-lowering effect throughout the meal.